Published in Annu Rev Med on January 01, 1996
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest (1997) 2.57
The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys (2008) 1.36
Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. J Exp Med (1999) 1.24
Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med (2014) 1.12
Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation (2013) 1.07
A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells. Proc Natl Acad Sci U S A (2003) 1.05
Role of nitric oxide in tolerance of plants to abiotic stress. Protoplasma (2010) 1.02
Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation. Neurosurgery (2009) 0.96
The role of nitric oxide in passive leg movement-induced vasodilatation with age: insight from alterations in femoral perfusion pressure. J Physiol (2015) 0.93
PDE1 isozymes, key regulators of pathological vascular remodeling. Curr Opin Pharmacol (2011) 0.90
Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors. Vasc Health Risk Manag (2009) 0.89
Targeting endothelial dysfunction in vascular complications associated with diabetes. Int J Vasc Med (2011) 0.89
Nitric oxide diffusion rate is reduced in the aortic wall. Biophys J (2007) 0.88
Red blood cell clearance in inflammation. Transfus Med Hemother (2012) 0.87
Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biol (2001) 0.86
Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis. Br J Pharmacol (2002) 0.84
Acute exertion elicits a H2O2-dependent vasodilator mechanism in the microvasculature of exercise-trained but not sedentary adults. Hypertension (2014) 0.83
Nitric oxide transport in an axisymmetric stenosis. J R Soc Interface (2012) 0.81
Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels (2010) 0.81
Modulatory Role of Nitric Oxide/cGMP System in Endothelin-1-Induced Signaling Responses in Vascular Smooth Muscle Cells. Curr Cardiol Rev (2010) 0.79
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment. Vasc Health Risk Manag (2010) 0.78
Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function. Mol Med (2008) 0.77
RGD-dependent binding of TP508 to integrin alphavbeta3 mediates cell adhesion and induction of nitric oxide. Thromb Haemost (2010) 0.77
Preparation and characterization of diazeniumdiolate releasing ethylcellulose films. J Mater Sci Mater Med (2008) 0.77
Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathways. Cardiovasc Res (2014) 0.75
Vascular function assessed by passive leg movement and flow-mediated dilation: initial evidence of construct validity. Am J Physiol Heart Circ Physiol (2016) 0.75
The Effect of Physical Activity on Passive Leg Movement-Induced Vasodilation with Age. Med Sci Sports Exerc (2016) 0.75
Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study. Medicine (Baltimore) (2016) 0.75
Influence of authentic nitric oxide on basal cytosolic [Ca2+] and Ca2+ release from internal stores in human platelets. Br J Pharmacol (1996) 0.75
In vivo antithrombotic synergy of oral heparin and arginine: endothelial thromboresistance without changes in coagulation parameters. Thromb Haemost (2006) 0.75
Constitutively synthesized nitric oxide is a physiological negative regulator of mammalian angiogenesis mediated by basic fibroblast growth factor. Int J Exp Pathol (2000) 0.75
Similarities in the Metabolic Reprogramming of Immune System and Endothelium. Front Immunol (2017) 0.75
Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke. Stroke Vasc Neurol (2017) 0.75
Effects of diaspirin crosslinked hemoglobin infusion in treadmill-exercised swine. Heart Vessels (1999) 0.75
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem (1992) 2.25
Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev (1987) 2.24
Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell (1986) 1.98
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89
Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest (1997) 1.87
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med (2001) 1.58
Nucleotide sequences of the human and mouse atrial natriuretic factor genes. Science (1984) 1.51
Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol (2000) 1.49
Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest (1988) 1.42
Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem (1998) 1.34
Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest (1997) 1.28
Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol Chem (1996) 1.24
Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. J Biol Chem (1990) 1.21
Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation (2000) 1.19
Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res (1996) 1.19
Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res (1998) 1.16
Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest (1990) 1.16
Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. Am J Physiol (1999) 1.14
Identification of cDNA encoding an additional alpha subunit of a human GTP-binding protein: expression of three alpha i subtypes in human tissues and cell lines. Proc Natl Acad Sci U S A (1988) 1.13
Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene (2007) 1.11
Regional and maturation-associated expression of endothelin 2 in rat gastrointestinal tract. J Histochem Cytochem (1995) 1.10
Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science (1985) 1.10
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest (1996) 1.07
Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res (1995) 1.06
The immunoreactive region in a novel autoantigen contains a nuclear localization sequence. Clin Immunol Immunopathol (1994) 1.03
Cis-acting sequences that modulate atrial natriuretic factor gene expression. Proc Natl Acad Sci U S A (1988) 1.03
Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol (1999) 1.02
Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology (2000) 1.00
Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol (2001) 0.99
Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J Clin Invest (1999) 0.97
Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation (2000) 0.95
Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res (2001) 0.94
Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation (1996) 0.93
cAMP regulates soluble guanylate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am J Physiol (1993) 0.92
Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am J Physiol (1987) 0.91
Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. J Clin Invest (1986) 0.90
Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res (2000) 0.90
Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J Biol Chem (1997) 0.89
Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am J Physiol (1995) 0.89
Antenatal glucocorticoid corrects pulmonary immaturity in experimentally induced congenital diaphragmatic hernia in rats. Pediatr Res (1994) 0.89
Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci (1999) 0.87
The gene for the alpha i1 subunit of human guanine nucleotide binding protein maps near the cystic fibrosis locus. Am J Hum Genet (1988) 0.86
Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles. Endocrinology (1988) 0.85
A serum protease cleaves proANF into a 14-kilodalton peptide and ANF. Am J Physiol (1987) 0.83
Subtype-specific increase in G-protein alpha-subunit mRNA by interleukin 1 beta. FEBS Lett (1989) 0.83
Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.83
Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology (1999) 0.82
Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol (1985) (1994) 0.82
Expression of the endothelin-1 and oxytocin genes in the hypothalamus of the pregnant rat. Brain Res (1994) 0.81
Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. J Biol Chem (1992) 0.81
Proatrial natriuretic factor is phosphorylated by rat cardiocytes in culture. J Biol Chem (1987) 0.81
Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol (1996) 0.80
Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells. J Physiol Pharmacol (2010) 0.80
Inhibition of lung phosphodiesterase improves responsiveness to inhaled nitric oxide in isolated-perfused lungs from rats challenged with endotoxin. Intensive Care Med (2001) 0.80
Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease. Mol Chem Neuropathol (1997) 0.79
Selective pulmonary vasodilation induced by aerosolized zaprinast. Anesthesiology (1998) 0.79
ABO blood group and inhaled nitric oxide in acute respiratory distress syndrome. Lancet (1998) 0.79
Inhibition of nitric oxide synthase prevents hyporesponsiveness to inhaled nitric oxide in lungs from endotoxin-challenged rats. Anesthesiology (1999) 0.79
In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. Am J Physiol (1995) 0.79
Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol (2001) 0.78
Cosegregation of the endothelin-3 locus with blood pressure and relative heart weight in inbred Dahl rats. J Hypertens (1994) 0.78
Nitric oxide responses of air-breathing and water-breathing fish. Am J Physiol (1995) 0.78
Regulation of endothelial NO synthase mRNA stability: RNA-binding proteins crowd on the 3'-untranslated region. Circ Res (1999) 0.78
Bartter's syndrome and the atrial natriuretic factor gene. Hypertension (1986) 0.77
The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice. Lab Invest (1995) 0.76
Maturational changes in ovine pulmonary vascular responses to inhaled nitric oxide. Pediatr Pulmonol (1999) 0.76
Localization of rat genes in the nitric oxide signaling pathway: candidates for the pathogenesis of complex diseases. Mamm Genome (1999) 0.75
Atrial natriuretic factor: assessment of its structure in atria and regulation of its biosynthesis with volume depletion. J Mol Cell Cardiol (1986) 0.75
Molecular approaches to the study of atrial natriuretic factor. Am J Med Sci (1987) 0.75
Molecular studies of the atrial natriuretic factor gene. Hypertension (1985) 0.75
Inhaled nitric oxide does not alter endotoxin-induced nitric oxide synthase activity during rat lung perfusion. J Appl Physiol (1985) (1995) 0.75
Functions of G-protein subunits. Cold Spring Harb Symp Quant Biol (1988) 0.75